Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

Overview of attention for article published in Trials, March 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 38 X posts from 36 X users, with an upper bound of 104,197 followers.

RT @thumph10: Rona Smith from the Cambridge Vasculitis group presenting the results from RITAZAREM - trial assessing rituximab vs azathiopr…

RT @thumph10: Rona Smith from the Cambridge Vasculitis group presenting the results from RITAZAREM - trial assessing rituximab vs azathiopr…

RT @thumph10: Rona Smith from the Cambridge Vasculitis group presenting the results from RITAZAREM - trial assessing rituximab vs azathiopr…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 34 additional X posts.